FdaApplication
NDA 050621
Identifiers
- fda_app_no: NDA050621
Properties
| Property | Value |
|---|---|
| applicant_name | LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO |
| application_type | NDA |
| approval_date | 1989-04-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUPRAX | CEFIXIME | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| SUPRAX | CEFIXIME | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
2 products